Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ana Oaknin, MD
Head of Gynaecologic Cancer Program, Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d'Hebron
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Juravinski Cancer Centre
Hamilton, Ontario, on, Canada
- Mcgill University
Montreal, Quebec, Canada
- Bc Cancer-Vancouver
Vancouver, Vancouver, BC, Canada
- Fondazione Irccs Istituto Nazionale Dei Tumori
Milan, Italy
- Istituto Europeo Di Oncologia
Milan, Italy
- Erasmus Mc Kanker Instituut
Rotterdam, Netherlands
- Hospital Universitario la Paz
Madrid, Fuencarral-El Pardo, Spain
- Hospital Universitari Vall D'Hebron
Barcelona, Horta-Guinardó, Spain
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Stanford University Medical Center
Palo Alto, California, United States
- University of Michigan
Ann Arbor, Michigan, United States
- New York University
New York, New York, United States
- Mary Crowley Cancer Research
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Nov 2017
- Primary completion
- 27 Jul 2022
- Completion
- 29 Mar 2023
- Last update posted
- 21 Oct 2024
- Registered enrollment
- 71
- Registry id
- NCT03345485
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.